The effects of long-term treatment with a novel angiotensin I converting enzyme (ACE) inhibitor, trandolapril, on ACE activity and cardiac function in rats with chronic heart failure (CHF) were examined and compared with those of captopril and enalapril. Left coronary artery ligation of rats resulted in decreases in mean arterial pressure, left ventricular systolic pressure, dP/dt, cardiac output and stroke volume indices, and increases in left ventricular enddiastolic pressure and systemic vascular resistance 12 weeks after the operation. A significant increase in ACE activity of the myocardium, but not that of serum or other tissues, was detected in the CHF rat 12 weeks after the operation. Oral treatment with ACE inhibitors (10mg/kg/day captopril, 10mg/kg/day enalapril or 3mg/kg/day trandolapril) from the 2nd to 12th week, attenuated the changes in cardiac output and stroke volume indices, left ventricular enddiastolic pressure and systemic vascular resistance of the CHF rat. Treatment also attenuated the increase in the cardiac ACE activity of CHF rats. A close relationship between the decrease in cardiac output index and the increase in cardiac ACE activity was detected. The results suggest that trandolapril, like other ACE inhibitors, exerts a beneficial effect on cardiac function in the CHF rat and that one of the mechanisms for this effect is attenuation of elevated cardiac ACE activity. (Jpn Heart J 36: 451-463, 1995) 
gested that an increase in cardiac ACE activity is a mechanism responsible for cardiac remodeling and hypertrophy , which are involved in progressive heart failure. Several reports have shown that ACE inhibitors such as enalapril and perindopril reversed the increased cardiac ACE activity in CHF rats. [11] [12] [13] Trandolapril is a newly developed ACE inhibitor which is a prodrug and has a relatively long half-life in plasma.14,15) Fornes et al16) showed that long-term treatment with trandolapril inhibited cardiac remodeling and prolonged survival in rats with CHF. However, the effect of long-term treatment with trandolapril on cardiac ACE activity in the failing heart has not been fully understood. The present study was undertaken to determine whether trandolapril, like other ACE inhibitors, reverses the increased cardiac ACE activity and, if so, whether the reversal is associated with an improvement in the impaired cardiac function of CHF animals.
MATERIALS AND METDS
Animals: Male Wistar rats (SLC, Shizuoka, Japan), weighing 200-220g, were used in the present study. The animals were with fed standard rat chow and tap water ad libitum, housed in polyethylene cages, and maintained on a 12-hour light and 12-hour dark cycle before and during the experiment, according to the Guidelines of Experimental Animal Care issued by the Prime Minister's Office of Japan. Coronary artery ligation: Myocardial infarction was induced by occlusion of the left coronary artery according to the method of Selye et al17) with a minor modification as described previously.18) Animals were lightly anesthetized with ether. The skin was incised along the left sternal border. The fourth rib was cut proximal to the sternum. The pericardial sac was perforated, and the heart was exteriorized through the intracostal space. The left coronary artery was ligated approximately 2mm from its origin with a suture of 5-0 silk. The heart was then repositioned in the chest. During the operation, the rats were maintained with positive-pressure ventilation. Sham-operated animals were treated similarly except that the suture around the coronary artery was not tied. Hemodynamic and biochemical assessments were performed 1 and 12 weeks after operation. Preoperated rats (control) were also used for measurements of baseline parameters. In a previous study, it was found that left ventricular end-diastolic pressure (LVEDP) increased one week after the operation. Cardiac output and stroke volume indices were not altered 4 weeks, but were significantly decreased 8 and 12 weeks after the operation.18) Thus, we consider the 12th week after the operation as representing a chronic stage, and the first week an early stage of heart failure. Student's t-test. The effects of ACE inhibitors on tissue weight, hemodynamics and ACE activity were statistically analyzed using analysis of variance followed by Dunnett's t-test. Pearson's formula was used to determine the relationship between ACE activity and cardiac output index. A confidence level of more than 95% was considered significant.
RESTS
Animal mortality:
In the present study, 82 rats were subjected to coronary artery ligation. Eight rats died within 24 hrs, 8 from 1 to 7 days, 13 from 7 to 14 days, and 2 from 2 to 12 weeks after the operation. Fifty-three CHF rats with or without ACE inhibitor treatment were used for the experiments 12 weeks after the operation. The survival of the CHF rats was not affected by treatment with any ACE inhibitor. Tissue weight and infarct size: The effects of trandolapril treatment on tissue weight of the CHF rat are shown in Table I . A significant decrease in body weight of CHF rats was observed, and the other parameters were not altered at the 1st week after the operation. The ratios of both right ventricular weight/body weight and lung weight/body weight of CHF rats increased similarly 12 weeks after the operation, regardless of treatment with or without ACE inhibitors. The infarct area of the untreated CHF rat was approximately 40% of the left ventricle. Treatment with ACE inhibitors did not change the infarct size of CHF rats. of CHF rats were determined (Tables IV and V) . Left ventricular ACE activity increased approximately two-fold in CHF rats 1 week after the operation and the increased activity was also detected 12 weeks after the operation. Similarly, right ventricular ACE activity in CHF rats was also higher than that of pre-operated rats. Scar tissue ACE activity in CHF rats was markedly increased compared In the present study, there were no significant differences in mortality between the untreated and treated CHF animals throughout the experiment. As described in the Introduction, several reports have shown that ACE inhibitor treatment reduced the mortality in CHF rats after coronary artery ligan. 2, 16) Differences in the results between those and the present study may be due to the fact that their rats were studied at a relatively long period after coronary artery ligation (1 year or 9 months after the operation). In the present study, the mortality in CHF rats was examined over a period of 12 weeks after the operation. Thus, prolongation of survival by ACE inhibitor treatment may occur at a later stage of CHF.
It is believed that reduction in afterload by treatment with ACE inhibitors plays a role in the improvement of cardiac function of CHF animals. Raya et al26) reported that long-term treatment with hydralazine, a direct vasodilator, did not improve cardiac function in rats after myocardial infarction. Therefore, it is unlikely that the effects of long-term ACE inhibitor treatment on CHF depend solely on the reduction in afterload. Cardiac ACE activities in both ventricles increased 1 week after the operation, and this level was sustained for 12 weeks. However, the ACE activities of the serum and other tissues had not increased 1 and 12 week(s) after the operation except for serum activity in the first week. It has been shown that the reninangiotensin-aldosterone system is activated during acute heart failure with low cardiac output.27,28) In contrast, during the development of CHF, the plasma renin activity and aldosterone concentration returned toward normal levels29) Although the exact mechanism for elevation of cardiac ACE activity in heart failure remains unclear, it is possible that the increase in ventricular wall tension, caused by scar tissue formation, LVEDP and SVR, is a direct stimulus,30) and that an increase in myocardial sympathetic nerve activity is involved in the elevation of cardiac ACE activity.10)
The increase in cardiac ACE activity may be associated with an increase in local angiotensin II synthesis, which appears to directly stimulate protein synthesis, and the induction of proto-oncogene and growth factor.30-35) Such stimulation may lead to ventricular hypertrophy and remodeling. Thus, it is probable that the increase in cardiac ACE activity contributes to the process of cardiac remodeling in rats after myocardial infarction, which eventually leads to the development of CHF in addition to reduction in preload and/or afterload.4,16) The attenuation in the elevation of cardiac ACE activity may play a role in prevention of cardiac remodeling and failure in ACE inhibitor-treated animals.
We also observed that long-term treatment with trandolapril and the other ACE inhibitors employed inhibited the increase in cardiac ACE activity in CHF rats. Furthermore, a close relationship was observed between the increase in left ventricular ACE activity and the decrease in cardiac output index. These findings suggest that attenuation in the elevation of ACE activity and local synthesis of angiotensin II is related to the improvement in cardiac function after myocardial infarction. Considering these observations, it could be concluded that trandolapril treatment prevents the development of CHF associated with attenuation of elevated cardiac ACE activity.
In the present study, an increase in ACE activity of scar tissue was observed in CHF rats 12 weeks after the operation. We also observed that long-term treatment with ACE inhibitors attenuated the ACE activity of scar tissue (>70% inhibition) 12 weeks after the operation (data not shown). ACE activity in scar tissue may originate from macrophages and fibroblasts because the presence of ACE has been demonstrated in macrophages and fibroblasts.13,36) However, whether or not this enzyme inhibition is involved in the development of CHF or the effects of ACE inhibitors remains unclear.
We determined the efficacy of three ACE inhibitors with respect to attenuation of cardiac ACE activity and improvement of cardiac output index. The attenuation of cardiac ACE activity and the improvement of cardiac output index were similar in the CHF animals following treatment with 10mg/kg captopril, 10mg/kg enalapril, or 3mg/kg trandolapril. A similar hypotensive effect has been reported to occur in spontaneous hypertensive rats following a single administration of 30mg/kg captopril, 10mg/kg enalapril and 1mg/kg trandolapril37,38) or following administration of 100mg/kg/day captopril, 25mg/ kg/day enalapril and 5mg/kg/day trandolapril,39) respectively, for 8 consecutive days. Thus, the efficacy of these agents on cardiac ACE activity and cardiac output index in this study would be similar to their hypotensive effects.
